Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-30

Clinical Trial Update: Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating long-term outcomes after serial lidocaine infusion for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Mahidol University | Conditions: Peripheral Neuropathy | Phase 3 | Status: COMPLETED